Marquette Asset Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Marquette Asset Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,180	Closed	-$174K	–	402
2021 Q4	$174K	Sell	5,180 -2,761	-35%	-$76.9K	0.04%	110
2021 Q3	$204K	Hold	7,941	–	–	0.05%	96
2021 Q2	$110K	Hold	7,941	–	–	0.02%	131
2021 Q1	$84K	Hold	7,941	–	–	0.02%	136
2020 Q4	$64K	Hold	7,941	–	–	0.01%	151
2020 Q3	$59K	Buy	+7,941	New	+$70.5K	0.02%	132

Other funds holding OPNT

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OCM

Ovata Capital Management Hong Kong $1.33B AUM 5.69% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Marquette Asset Management's OPNT Position: Q1 2022 in Review

Marquette Asset Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2022, closing a stake of 5,180 shares — an estimated $174K sold.

Marquette Asset Management first reported a position in OPNT in Q3 2020 and held it in 6 quarters. The position peaked at $204K in Q3 2021. 41 funds tracked by Wall St. Rank hold OPNT as of Q1 2022.

Marquette Asset Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Marquette Asset Management sold 5,180 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $174K.
Marquette Asset Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Marquette Asset Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $204K in Q3 2021.
41 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Marquette Asset Management's 13F filing for Q1 2022, filed 26 Apr 2022.